A Patient With Locally Advanced Mismatch-Repair-Deficient Pancreatic Ductal Adenocarcinoma Successfully Treated With Neoadjuvant Immunotherapy

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a dismal prognosis. Approximately 30% of patients present with locally advanced disease, defined as pancreatic tumor with invasion to adjacent structures, including the vasculatures that preclude an upfront surgical resection....

Descripción completa

Detalles Bibliográficos
Autores principales: Cox, Ronald E, Mahipal, Amit, Chakrabarti, Sakti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144075/
https://www.ncbi.nlm.nih.gov/pubmed/34055508
http://dx.doi.org/10.7759/cureus.14640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144075/
https://www.ncbi.nlm.nih.gov/pubmed/34055508
http://dx.doi.org/10.7759/cureus.14640

Ejemplares similares